RxSight (RXST) Net Income (2020 - 2026)

RxSight (RXST) has 7 years of Net Income data on file, last reported at -$15.9 million in Q1 2026.

• For the quarter ending Q1 2026, Net Income fell 93.94% year-over-year to -$15.9 million; the trailing twelve-month figure through Mar 2026 stood at -$46.6 million (down 5516.72% YoY), and the FY2025 full-year result was -$38.9 million, down 79377.55% from the prior year.
• Net Income for Q1 2026 stood at -$15.9 million, down from -$9.2 million in the prior quarter.
• Across five years, Net Income topped out at $51.1 million in Q4 2022 and bottomed at -$17.6 million in Q1 2022.
• The 5-year median for Net Income is -$9.8 million (2025), against an average of -$3.2 million.
• Peak annual rise in Net Income reached 424.74% in 2022, while the deepest fall reached 158.57% in 2022.
• A 5-year view of Net Income shows it stood at $51.1 million in 2022, then fell by 22.93% to $39.4 million in 2023, then slumped by 45.53% to $21.5 million in 2024, then slumped by 142.63% to -$9.2 million in 2025, then plunged by 73.56% to -$15.9 million in 2026.
• The last three Net Income figures came in at -$15.9 million (Q1 2026), -$9.2 million (Q4 2025), and -$9.8 million (Q3 2025), per Business Quant data.

Peer Comparison